Influx of Unauthorized E-Cigarettes from China Floods US Market
According to a report by the Associated Press on December 31, 2023, US authorities are taking action to seize more unauthorized e-cigarette products. However, a large number of new products from China continue to flood the American market.
According to government and industry data, this signifies that the status of e-cigarettes in the American market is highly chaotic, with a value reaching $7 billion.
According to data compiled by Circana Analytics, the number of unique e-cigarette products sold in the American market has exceeded 11,500, marking a 27% increase compared to the 9,000 varieties available in June of this year.
Psychologist Bonnie Halpern-Felsher from Stanford University warns that if the Food and Drug Administration (FDA) in the United States bans a certain product, manufacturers simply make slight adjustments and reintroduce it into the market, making it easily accessible for children.
According to sales data collected from gas stations, convenience stores, and other locations, disposable e-cigarettes dominated the market for new products, generating a sales revenue of $3.2 billion in the first 11 months of this year. The FDA has authorized certain e-cigarette products targeting adults and is currently examining the products of several major companies, including Juul.
Regulatory authorities argue that almost all other e-cigarettes are considered illegal. Despite record-breaking seizures of these products, e-cigarette sales continue to rise.
According to the FDA's database, the United States rejected 148 containers of products containing tobacco from entering the country last month, nearly all of which were e-cigarette products from China. Typically, imported goods that are denied entry are destroyed. As of November, US authorities have rejected 374 such goods this year, compared to only 118 by this time last year.
In July 2022, the FDA banned several dozen e-cigarette flavors manufactured by Chinese manufacturer Fume, including Pineapple Ice and Blue Razz. Despite a decline in sales following the ban, the company introduced new products and recorded $42 million in sales in the third quarter of 2023, with 98% of sales coming from products not listed by the FDA.
The transportation methods in the industry have also raised doubts about the effectiveness of import restrictions. In July of this year, FDA and customs officials seized illegal e-cigarettes worth $18 million, including the leading brand Elf Bar. However, these goods were labeled as shoes, toys, and other items, rather than e-cigarettes, which forced officials to open more than 24 shipping containers for individual checks.
The FDA has not yet set a timetable for updating its import list, but has noted that it is closely monitoring cases of companies attempting to evade detection. King of the FDA stated, "The FDA has various means to take action against these tactics.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.